Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OGC | Ann: OceanaGold Commences Milling at Haile Gold Mine | 14:20 | 0 | 776 | |||
|
|||||||
OGC | Ann: OceanaGold Announces 2017 Production and Cost Guidance | 13/12/16 | 0 | 666 | |||
|
|||||||
OGC | Ann: OGC Provides An Update On Its Global Exploration Program | 13/12/16 | 0 | 672 | |||
|
|||||||
OGC | Ann: OceanaGold Corporation (NS) (“OGC”) – Delisting | 30/11/16 | 0 | 660 | |||
|
|||||||
OGC | Ann: OceanaGold Announces Intent To Delist From The New Zealand | 28/11/16 | 0 | 641 | |||
|
|||||||
OGC | Ann: OGC Didipio Operation Wins PMIEA Awards | 21/11/16 | 0 | 622 | |||
|
|||||||
OGC | Ann: Final Director’s Interest Notice | 17/11/16 | 0 | 646 | |||
|
|||||||
OGC | Ann: Q3 2016 Results Presentation | 28/10/16 | 0 | 627 | |||
|
See All Discussions